Anyone who got sick with COVID-19 during the summer wave in South Florida has some protection against a future infection, but ...

Sheena Mitchell of A WonderCare Podcast spoke to Pat Kenny about the importance of vaccine accessibility this winter ...

Starting Nov. 4, babies born in 2024 can get Beyfortus — also known as nirsevimab — to protect against severe illness from ...

NOROVIRUS cases have surged over the past two weeks, raising fears as Brits brace for a trio of rampant winter viruses.

As Sanofi declares strong early sales for Beyfortus in its second RSV season, the French pharma is confident that it would ...

Fears have grown for coming months over a potential triple threat from a rise in flu, a new Covid variant and RSV infections.

Arexvy is currently approved for active immunization for the prevention of LRTD caused by RSV in individuals 60 years of age and older, and those 50 to 59 years of age who are at increased risk for ...

The CDC's vaccine policy advisors haven't budged on new RSV guidance, remaining unconvinced that younger adults at higher ...

GSK unveils new Arexvy data showing strong protection in adults 18-49 at risk for RSV. The vaccine could broaden coverage for ...

The Mississippi State Department of Health encourages everyone to get appropriate updated vaccinations to avoid severe ...

Important information new parents need to know about Respiratory Syncytial Virus, or RSV. It comes around when the weather ...